A radioimmunoimaging and MIRD dosimetry treatment planning program for radioimmunotherapy
- 1 May 1996
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 23 (4) , 525-532
- https://doi.org/10.1016/0969-8051(96)00036-4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Validation of a dose-point kernel convolution technique for internal dosimetryPhysics in Medicine & Biology, 1995
- Tumor activity confirmation and isodose curve display for patients receiving iodine-131-labeled 16.88 human monoclonal antibodyCancer, 1994
- The biologic window for chimeric l6 radioimmunotherapyCancer, 1994
- Photon contribution to tumor dose from considerations of 131 I radiolabeled antibody uptake in liver, spleen, and whole bodyMedical Physics, 1993
- SPECT volume quantitation: Influence of spatial resolution, source size and shape, and voxel sizeMedical Physics, 1991
- Preliminary validation of the opposing view method for quantitative gamma camera imagingMedical Physics, 1989
- Treatment of B cell malignancies with131I LYM-1 monoclonal antibodiesInternational Journal of Cancer, 1988
- Requirements for a treatment planning system for radioimmunotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1985
- External imaging techniques for quantitation of distribution of I-131 F (ab ′)2 fragments of monoclonal antibody in humansMedical Physics, 1984
- Calculating dose from remaining body activity: A comparison of two methodsMedical Physics, 1979